Glenn Monteith, Vice-President, Innovation and Health Sustainability, Innovative Medicines Canada bh in Brief Innovative Medicines Canada (IMC) is the national voice of Canada’s innovative pharmaceutical industry. IMC advocates for policies that enable the discovery, development and commercialization of innovative medicines and vaccines that improve the lives of all Canadians. IMC supports its members’ commitment to … Continue reading Benefits: A Holistic Approach in an Age of Rapid Innovation